• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】59613

【品名】(1R,2S,4R,5R,8R,9S,11R)-2-({[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}methyl)-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylic acid

【CA登记号】

【 分 子 式 】C27H40O8

【 分 子 量 】492.6098

【元素组成】C 65.83% H 8.18% O 25.98%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(I)

Sordarin (I) was isolated from culture broths of Sordaria araneosa. Protection of the carboxyl group of (I) as the benzhydryl ester (II) was effected by treatment with diphenyl diazomethane. The 2'-hydroxyl group of (II) was subsequently blocked as the carbonate ester (III) by selective acylation with benzyl chloroformate in the presence of DMAP. Subsequent esterification of the 3'-hydroxyl of (III) with octanoyl chloride (IV) furnished the octanoate ester (V). The benzhydryl ester and benzyl carbonate protecting groups of (V) were finally removed by catalytic hydrogenation over Pd/C.

1 Fraile, M.T.; Ruiz, J.R.; Gómez de las Heras, F.; García-Ochoa, S.; Arribas, E.M.; Castro, J.; Clemens, I.R.; Cuevas, J.C.; Chicharro, J.; Antifungal sordarins. Synthesis and structure-activity relationships of 3'-O-substituted derivatives. Bioorg Med Chem Lett 2002, 12, 2, 117.
2 Hayes, M.; Wildman, H.; Dawson, M.; Chalk, P.; Hall, R.; Ruiz Gomez, J.R. (GlaxoSmithKline plc); Antifungal sordarin derivs.. EP 0711783; EP 0791007; JP 1999502188; US 6054478; WO 9614327 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 59613 (1R,2S,4R,5R,8R,9S,11R)-2-({[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}methyl)-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylic acid C27H40O8 详情 详情
(II) 59614 benzhydryl (1R,2S,4R,5R,8R,9S,11R)-2-({[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}methyl)-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C40H50O8 详情 详情
(III) 59615 benzhydryl (1R,2S,4R,5R,8R,9S,11R)-2-{[((2R,3S,4R,5S,6R)-3-{[(benzyloxy)carbonyl]oxy}-4-hydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy]methyl}-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C48H56O10 详情 详情
(IV) 11123 Octanoyl chloride; n-Caprylyl chloride;Capryloyl chloride 111-64-8 C8H15ClO 详情 详情
(V) 59616 benzhydryl (1R,2S,4R,5R,8R,9S,11R)-2-({[(2R,3S,4R,5R,6R)-3-{[(benzyloxy)carbonyl]oxy}-5-methoxy-6-methyl-4-(octanoyloxy)tetrahydro-2H-pyran-2-yl]oxy}methyl)-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C56H70O11 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

The hydrolysis of Zofimarin (I) with NaOMe in methanol gives the sodium salt of the deacylated compound (II), which is treated with Pmb-Cl in DMF to yield the p-methoxybenzyl ester (III). The protection of the formyl group of (III) by means of ethyleneglycol, trimethyl orthoformate and TsOH affords the ethylene ketal (IV), which is oxidized at the vicinal diol group by means of NaIO4 in methanol/water to provide the dialdehyde (V). The reductocyclization of (V) with allylamine (VI) by means of NaBH3CN and AcOH in acetonitrile leads to the perhydro oxazepine derivative (VII), which is deallylated by means of Rh(PPh3)3Cl in aqueous ethanol to give compound (VIII). The alkylation of (VIII) with 2-methylallyl bromide (IX) by means of NaHCO3 and NaI in ethanol yields the protected precursor (X), which is finally treated with TFA in dichloromethane to provide the target zofimarin derivative.

1 Fukuoka, T.; Kamai, Y.; Kakuta, M.; Kaneko, S.; Arai, M.; Uchida, T.; Konosu, T.; Kuwahara, S.; Design, synthesis, and in vitro activity of RS-135853, a novel zofimarin-related antifungal agent. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-824.
2 Kaneko, S.; Uchida, T.; Arai, M.; Kounosu, T. (Sankyo Co., Ltd.); Zofimarin derivs. having an oxazepan ring. JP 2002161086; WO 0223541 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 60326 (1R,2S,4R,5R,8R,9S)-9-formyl-2-[({(2R,3S,4S,5R,6R)-4-[(2Z,4E)-2,4-hexadienoyloxy]-3-hydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl}oxy)methyl]-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylic acid C33H46O9 详情 详情
(II) 59613 (1R,2S,4R,5R,8R,9S,11R)-2-({[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}methyl)-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylic acid C27H40O8 详情 详情
(III) 60327 4-methoxybenzyl (1R,2S,4R,5R,8R,9S)-2-({[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}methyl)-9-formyl-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C35H48O9 详情 详情
(IV) 60328 4-methoxybenzyl (1R,2S,4R,5R,8R,9S)-2-({[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}methyl)-9-(1,3-dioxolan-2-yl)-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C37H52O10 详情 详情
(V) 60329 4-methoxybenzyl (1R,2S,4R,5R,8R,9S)-9-(1,3-dioxolan-2-yl)-13-isopropyl-2-{[((1R)-1-{[(1R,2R)-2-methoxy-1-methyl-3-oxopropyl]oxy}-2-oxoethyl)oxy]methyl}-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C37H50O10 详情 详情
(VI) 13672 Allylamine; 2-Propen-1-amine 107-11-9 C3H7N 详情 详情
(VII) 60330 4-methoxybenzyl (1R,2S,4R,5R,8R,9S)-2-({[(2R,6S,7R)-4-allyl-6-methoxy-7-methyl-1,4-oxazepan-2-yl]oxy}methyl)-9-(1,3-dioxolan-2-yl)-13-isopropyl-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C40H57NO8 详情 详情
(VIII) 60331 4-methoxybenzyl (1R,2S,4R,5R,8R,9S)-9-(1,3-dioxolan-2-yl)-13-isopropyl-2-({[(2R,6S,7R)-6-methoxy-7-methyl-1,4-oxazepan-2-yl]oxy}methyl)-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C37H53NO8 详情 详情
(IX) 40015 3-bromo-2-methyl-1-propene 1458-98-6 C4H7Br 详情 详情
(X) 60332 4-methoxybenzyl (1R,2S,4R,5R,8R,9S)-9-(1,3-dioxolan-2-yl)-13-isopropyl-2-({[(2R,6S,7R)-6-methoxy-7-methyl-4-(2-methyl-2-propenyl)-1,4-oxazepan-2-yl]oxy}methyl)-5-methyltetracyclo[7.4.0.0~2,11~.0~4,8~]tridec-12-ene-1-carboxylate C41H59NO8 详情 详情
Extended Information